glen tullman
-
Glen Tullman’s 5 Predictions for Healthcare’s Future
Glen Tullman — CEO of care navigation company Transcarent, as well as former CEO of Allscripts and Livongo — discussed what he thinks the future of healthcare will look like during the HIMSS conference in Chicago. He laid out five predictions, including an increased focus on consumer expectations and more investment in AI.
-
Why 1 VC is Fed Up with the Concept of Digital Health Unicorns
There are currently 97 global digital health companies that are considered unicorns. But getting caught up with the idea of digital health unicorns isn’t very sustainable, according to Emilly Melton, managing partner at Threshold Ventures. Instead of focusing too much on their valuations, she recommended that startups simply focus on getting the capital they need in order to reach the next stage of inflection.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
How are employers and providers collaborating in the new surgery health and care experience?
Surgery management has emerged as a key area where employers are collaborating with providers through companies like Transcarent to provide more informed guidance on surgery care delivery options for the best patient outcomes and experience.
-
Employee Benefits, Health Tech
Accolade CEO: Where Glen’s model is wrong; Glen Tullman: You can’t navigate a broken system
A battle of ideas from two prominent health tech CEOs came to life at the recently-concluded HLTH conference in Boston. It’s a substantive debate on solving healthcare’s entrenched problems and one worth having.
-
7wireVentures raises $150M for new digital health fund
7wireVentures, the venture capital firm that backed Livongo and other healthcare technology companies, raised $150 million for a new connected consumer fund. It’s already made two investments in patient navigation startups.
-
Using the magic of technology to deliver better health and care
Covid-19 has taken a particularly heavy toll on people with chronic conditions. We must make it easier for people to stay healthy at home by providing them with the information, supplies, and support they need delivered when and where they need it.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Five tidbits and takeaways from Livongo’s IPO filing
The chronic disease management company filed its S-1 paperwork on Friday, joining Change Healthcare, Phreesia and Health Catalyst as part of the raft of companies planning to go public after a nearly three year IPO drought in digital health.
-
Chronic disease management company Livongo officially files for IPO
The company, which will be listed on the Nasdaq exchange under the ticker symbol “LVGO,” offers tech-enabled solutions that help to monitor and manage people with chronic conditions like diabetes, hypertension and behavioral health issues.
-
Chronic care management company Livongo reportedly eyeing 2019 IPO
The Wall Street Journal reports that Mountain View, California-based Livongo has enlisted Morgan Stanley, Goldman Sachs Group Inc. and JPMorgan Chase & Co. as underwriters for an IPO that would value the company in excess of $1 billion.
-
Livongo CEO Zane Burke on his move from Cerner, big tech’s intersection with healthcare
Burke joined the Mountain View, California-based chronic disease management company late last year after spending more than two decades at EHR giant Cerner.
-
Livongo moves into behavioral health with acquisition of Denver-based myStrength
The myStrength news comes fresh off the heels of competitor Omada Health’s effort to add on similar services using technology developed by failed behavioral health startup Lantern.
-
Silicon Valley startup Livongo brings in new CFO as it rounds out executive team
New CFO Lee Shapiro has worked with Livongo Founder Glen Tullman for two decades, both at Allscripts and venture investing firm 7wire Ventures.